Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Busulfan Conditioning for Allo-HSCT
NCT00852163Phase 2Completed
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Mar 2007
- Primary completion
- Aug 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), primary myelofibrosis (PMF), chronic myelomonocytic leukemia (CMML), sponsored by Baylor Scott & White Research Institute. Started Mar 2007; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)primary myelofibrosis (PMF)chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT00852163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852163.